πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 160 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8440721

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440722

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8420669

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic recept

Laboratories Almirall, S.A. Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415396

Colchine compositions and methods

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415395

Colchicine compositions and methods

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8399493

Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors

Addex Pharmaceuticals S.A. Β· Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372872

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8344138

Triazinedione derivatives as GABAB receptor modulators

Addex Pharma, S.A. Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8334294

4,8-diphenyl-polyazanaphthalene derivatives

Almirall, S.A. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8299101

1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor m

Addex Pharma, S.A. Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283342

Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8

Almirall, S.A. Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258122

3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives

Almirall, S.A. Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258308

Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252937

1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

Addex Pharma, S.A. Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8242177

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptor

Almirall, S.A. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8178679

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptors

Almirall, S.A. Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173158

Methods of treating gastrointestinal disorders independent of the intake of food

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163775

Allosteric modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129405

Quinuclidine derivatives and medicinal compositions containing the same

Almirall Prodesfarma S.A. Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101637

Alkynyl derivatives as modulators of metatropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030331

Allosteric modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964615

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptor

Almirall, S.A. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960383

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7914990

Methods and products for in vitro genotyping

PROGENIKA BIOPHARMA, S.A. Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted